Fusion proteins for treatment of cancer

Porgador Angel (Inventor)

Research output: Patent


Chimeric polypeptides comprising a first moiety comprising an NKp44-derived peptide fused to a second moiety comprising one or more cell penetrating peptides (CPP), and polynucleotides encoding the same. Further provided are methods for treating, or ameliorating cancer.
Original languageEnglish
Patent numberIL249610
Priority date15/12/16
StatePublished - 31 Dec 2017


Dive into the research topics of 'Fusion proteins for treatment of cancer'. Together they form a unique fingerprint.

Cite this